FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Pharma Track and Trace Market Overview:

According to FutureWise analysis, the market for pharma track and trace solutions was US$ 2.1 Billion in 2022 and is anticipated to grow at a CAGR of 9.6% from 2023 to 2031.

The term "pharma track and trace market" describes the application of technologies and procedures to track and trace medicinal goods all the way through the supply chain, from manufacturing to distributing and selling. In addition to lowering the possibility of fraud, it also serves to guarantee the safety and authenticity of medicines. Pharma Track and trace (T&T) solutions assist companies in controlling their supply chain and reducing the dangers brought on by counterfeit items. They promote the hassle-free transportation of goods, provides product ID verification services, and help with logistics and packaging management. As a result, pharma T&T solutions are used for both personal and professional reasons since they save the cost of gasoline and insurance, give customer support, and deliver the most recent information via SMS alerts or emails.

The global pharma track and trace market is expected to grow significantly, driven by factors such as increasing demand for better supply chain visibility and security, rising instances of drug counterfeiting and product recalls, and regulatory requirements for serialization and track-and-trace. The market includes various solutions and services, such as serialization solutions, barcoding and labelling, tracking and tracing technologies, and consulting and implementation services. Pharma track and trace market includes various technologies, such as barcoding, RFID (radio frequency identification), and blockchain. Although barcoding is the most commonly used technology, RFID and blockchain are anticipated to expand significantly in the coming years due to their ability to improve supply chain transparency and security.

FutureWise Market Research has published a report that provides an insightful analysis of Pharma Track and Trace Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Pharma Track and Trace Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

Major players included in the Pharma Track and Trace Market:

AXWAY
METTLER-toLEDO INTERNATIONAL, INC.
TRAXEED
OPTEL VISION
IBM
SAP
TRACELINK, INC.
ADENTS
ANTARES VISION SRL
ACG

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Pharma Track and Trace Market:

To assist pharmaceutical companies in meeting their regulatory requirements and enhancing product safety, METTLER TOLEDO (Switzerland) unveiled a new Integrated Mark & Verify System in January 2022.

Anatres Vision acquired Adents High Tech International in February 2021. With this acquisition, the company expanded its offering of software solutions that can trace and monitor the entire supply chain. The acquisition expanded Anatres Vision's global footprint, particularly in France.

The market for pharmaceutical track and trace solutions has developed substantially over the past few years and is predicted to do so in the years to come. This growth may be ascribed to a variety of things, including the market's rising prevalence of counterfeit medications, governmental laws, and the pharmaceutical industry's requirement for supply chain transparency. According to estimates, up to 30% of medications in some nations may be counterfeit, which has led to a significant problem for the pharmaceutical sector regarding counterfeit drugs. These medications damage genuine pharmaceutical companies' reputations in addition to harming patients. As a result, there is a rising need for track and trace systems that can assist in identifying and halt the distribution of fake medications.

Government laws are a major factor in the market growth for pharmaceutical track and trace systems. Pharmaceutical businesses must use track and trace systems in order to guarantee the security and effectiveness of their goods. For instance, the Drug Supply Chain Security Act (DSCSA) in the United States mandates that all pharmaceutical firms deploy track and trace technologies by 2023. However, there are several obstacles that the market for pharmaceutical track and trace systems must overcome in order to expand. One of the key issues is the expense of putting these ideas into practise, which can be high, especially for smaller pharmaceutical businesses.

Pharma Track and Trace Market Segmentation:

By Product

Level 1
- Devices
- Barcodes
- RFID
- Printing and Marking Solutions
- Monitoring and Verification
- Others
Level 2
- Package Line Automation Software
Level 3
- Serialization Manager Software
Level 4
- Enterprise Level Solutions
- ERP
- Serial Number Manager
- EPCIS
Level 5
- Network Level Solutions
- Network EPCIS
- Serial Number Authentication, Exchange and Govt. Reporting
- Mobile Authentication

By Application

Serialization Solutions
Bottle Serialization
Label Serialization
Carton Serialization
Data Matrix Serialization
Aggregation Solutions
Case Aggregation
Bundle Aggregation
Pallet Aggregation
Others

By End User

Pharmaceutical Companies
Medical Device Companies
Healthcare Others

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The market for pharma track and trace systems is presently dominated by North America, and this dominance is anticipated to last throughout the projection period. The U.S has the greatest market share in North America. Although the COVID-19 pandemic has increased demand for pharma track and trace products in this region. The growing demand for pharmaceutical products, fueled by population development and rising healthcare costs, are the key reasons fueling growth in the North American region. As a result, many pharmaceutical companies are growing their operations in the region, which increases the demand for pharma track and trace technologies to satisfy legal requirements.

Competitive Landscape:

Tier 1 players- established companies in the market with major market share
Tier 2 players
New Entrants
Emerging players which are growing rapidly

FutureWise Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the of Pharma Track and Trace Market By Product, By Application, By End User and By Region.
To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Pharma Track and Trace Solutions Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Pharma Track and Trace Solutions Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Pharma Track and Trace Solutions Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Pharma Track and Trace Solutions Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Level 1
  1.1. Devices
  1.2. Barcodes
  1.3. RFID
  1.4. Printing and Marking Solutions
  1.5. Monitoring and Verification
  1.6. Others
  2. Level 2
  2.1. Package Line Automation Software
  3. Level 3
  3.1. Serialization Manager Software
  4. Level 4
  4.1. Enterprise Level Solutions
  4.2. ERP
  4.3. Serial Number Manager
  4.4. EPCIS
  5. Level 5
  5.1. Network Level Solutions
  5.2. Network EPCIS
  5.3. Serial Number Authentication,Exchange and Govt. Reporting
  5.4. Mobile Authentication
8. Pharma Track and Trace Solutions Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Serialization solutions
  2. Bottle Serialization
  3. Label Serialization
  4. Carton Serialization
  5. Data Matrix Serialization
  6. Aggregation Solutions
  7. Case Aggregation
  8. Bundle Aggregation
  9. Pallet Aggregation
  10. Others
9. Pharma Track and Trace Solutions Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Pharmaceutical Companies
  2. Medical Device Companies
  3. Healthcare Others
10. North America Pharma Track and Trace Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
11. Latin America Pharma Track and Trace Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
12. Europe Pharma Track and Trace Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
13. Asia Pacific Pharma Track and Trace Solutions Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
14. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
15. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. AXWAY
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. METTLER-toLEDO INTERNATIONAL, INC.
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. TRAXEED
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. OPTEL VISION
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. IBM
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. SAP
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. TRACELINK, INC.
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. ADENTS
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. ANTARES VISION SRL
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. ACG
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
17. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the regulations initiated by healthcare administrations
  5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients